Motu, Cordis

De Motu Cordis announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

De Motu Cordis

en | boerse | 67935067 |